Journal of the Chinese Medical Association
Volume 73, Issue 6 , Pages 319-324 , June 2010

Screening for Anti-lipase Properties of 37 Traditional Chinese Medicinal Herbs

  • Cheng-Dong Zheng

      Affiliations

    • Research Centre for Natural Medicinal Chemistry, College of Science, Yangling, Shaanxi, China
    • College of Life Sciences, Northwest Agriculture and Forestry University, Yangling, Shaanxi, China
    • ,
  • Ya-Qing Duan

      Affiliations

    • Research Centre for Natural Medicinal Chemistry, College of Science, Yangling, Shaanxi, China
    • College of Life Sciences, Northwest Agriculture and Forestry University, Yangling, Shaanxi, China
    • ,
  • Jin-Ming Gao

      Affiliations

    • Research Centre for Natural Medicinal Chemistry, College of Science, Yangling, Shaanxi, China
    • Corresponding Author InformationCorrespondence to: Dr Jin-Ming Gao, Research Centre for Natural Medicinal Chemistry, College of Science, Northwest Agriculture and Forestry University, Yangling 712100, Shaanxi, China
    • ,
  • Zhi-Gang Ruan

      Affiliations

    • College of Animal Science and Technology, Northwest Agriculture and Forestry University, Yangling, Shaanxi, China

Received 12 September 2009 ,Accepted 29 April 2010.

References 

  1. Kopelman PG . Obesity as a medical problem . Nature . 2000;404:635–643
  2. Jebb S . Obesity: causes and consequences . Womens Health Med . 2004;1:38–41
  3. Finer N . Medical consequences of obesity . Medicine . 2006;34:510–514
  4. Hedley AA , Ogden CL , Johnson CL , Carroll MD , Curtin LR , Flegal KM . Prevalence of overweight and obesity among US children, adolescents, and adults. 1999–2002 . JAMA . 2004;291:2847–2850
  5. Mokdad AH , Bowman BA , Ford ES , Vinicor F , Marks JS , Koplan JP . The continuing epidemics of obesity and diabetes in the United States . JAMA . 2001;286:1195–2000
  6. Styne DM . Childhood and adolescent obesity: prevalence and significance . Pediatr Clin North Am . 2001;48:823–854
  7. Glazer G . Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety . Arch Intern Med . 2001;161:1814–1824
  8. Bray GA . Medical therapy for obesity: current status and future hopes . Med Clin North Am . 2007;91:1225–1253
  9. Bray GA , Tartaglia LA . Medicinal strategies in the treatment of obesity . Nature . 2000;404:672–677
  10. Cheetham SC , Jackson HC , Vickers SP , Dickinson K , Jones RB , Heal DJ . Novel targets for the treatment of obesity: a review of progress . Drug Discov Today Ther Strateg . 2004;1:227–235
  11. Birari RB , Bhutani KK . Pancreatic lipase inhibitors from natural sources: unexplored potential . Drug Discov Today . 2007;12:879–889
  12. Mukherjee M . Human digestive and metabolic lipases: a brief review . J Mol Catal B Enzym . 2003;22:369–376
  13. Thomson AB , De Pover A , Keelan M , Jarocka-Cyrta E , Clandinin MT . Inhibition of lipid absorption as an approach to the treatment of obesity . Meth Enzymol . 1997;286:3–41
  14. Shi Y , Burn P . Lipid metabolic enzymes: emerging drug targets for the treatment of obesity . Nat Rev Drug Discov . 2004;3:695–710
  15. Weigle DS . Pharmacological therapy of obesity: past, present, and future . J Clin Endocrinol Metab . 2003;88:2462–2469
  16. Won SR, Kim SK, Kim YM, Lee PH, Ryu JH, Kim JW, et al. Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis . Food Res Intern . 2007;40:1046–1050
  17. Zhao HL , Kim YS . Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay . Arch Pharm Res . 2004;27:1048–1052
  18. Kwon CS, Sohn HY, Kim SH, Kim JH, Son KH, Lee JS, et al  Anti-obesity effects of Dioscorea nipponica Makino with lipase inhibitory activity in rodents . Biosci Biotechnol Biochem . 2003;67:1451–1456
  19. Ono Y , Hattori E , Fukaya Y , Imai S , Ohizumi Y . Anti-obesity effect of Nelumbo ucifera leaves extract in mice and rats . J Ethnopharmacol . 2006;106:238–244
  20. Mosmuller EWJ , Van Heemst JDH , Van Delden CJ , Franssen MCR , Engbersen JFJ . A new spectrophotometric method for the detection of lipase activity using 2,4-dinitrophenyl butyrate as a substrate . Biocatal Biotransformation . 1992;5:279–287
  21. Gargouri Y , Ransac S , Verger R . Covalent inhibition of digestive lipases: an in vitro study . Biochim Biophys Acta . 1997;1344:6–37
  22. Sharma N , Sharma VK , Seo SY . Screening of some medicinal plants for anti-lipase activity . J Ethnopharmacol . 2005;97:453–456
  23. Zheng J , He J , Ji B , Li Y , Zhang X . Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice . Asia Pac J Clin Nutr . 2007;16(Suppl):427–431
  24. Xie WD, Xing DM, Zhao YN, Su H, Meng Z, Chen YY, et al. A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit . Eur J Pharmacol . 2005;510:113–120
  25. Zhang CB, Teng L, Shi Y, Jin JH, Xue YF, Shang KG, et al. Effect of emodin on proliferation and differentiation of 3T3-L1 preadipocyte and FAS activity . Chin Med J . 2002;115:1035–1038
  26. Yang Y , Shang W , Zhou L , Jiang B , Jin H , Chen M . Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells . Biochem Biophys Res . 2007;353:225–230
  27. Xing WW , Wu JZ , Jia M , Du J , Zhang H , Qin LP . Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits . Biomed Pharmacother . 2009;63:457–462
  28. Du J, Sun LN, Xing WW, Huang BK, Jia M, Wu JZ, et al  Lipid-lowering effects of polydatin from Polygonum cuspi-datum in hyperlipidemic hamsters . Phytomedicine . 2009;16:652–658
  29. Liu J . Pharmacology of oleanolic acid and ursolic acid . J Ethnopharmacol . 1995;49:57–68

PII: S1726-4901(10)70068-X

doi: 10.1016/S1726-4901(10)70068-X

Journal of the Chinese Medical Association
Volume 73, Issue 6 , Pages 319-324 , June 2010

Article Tools